These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 30171718)
1. PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes. Negoita F; Blomdahl J; Wasserstrom S; Winberg ME; Osmark P; Larsson S; Stenkula KG; Ekstedt M; Kechagias S; Holm C; Jones HA J Cell Biochem; 2019 Jan; 120(1):343-356. PubMed ID: 30171718 [TBL] [Abstract][Full Text] [Related]
2. Autophagy and Lipid Droplets in the Liver. Martinez-Lopez N; Singh R Annu Rev Nutr; 2015; 35():215-37. PubMed ID: 26076903 [TBL] [Abstract][Full Text] [Related]
3. The Propensity of the Human Liver to Form Large Lipid Droplets Is Associated with PNPLA3 Polymorphism, Reduced INSIG1 and NPC1L1 Expression and Increased Fibrogenetic Capacity. Ferri F; Carotti S; Carpino G; Mischitelli M; Cantafora A; Molinaro A; Argenziano ME; Parisse S; Corsi A; Riminucci M; Lai Q; Mennini G; Spadetta G; Pugliese F; Rossi M; Morini S; Gaudio E; Ginanni Corradini S Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198853 [TBL] [Abstract][Full Text] [Related]
4. Oleic acid-induced defective autolysosome shows impaired lipid degradation. Lee DH; Ahn J; Jang YJ; Ha TY; Jung CH Biochem Biophys Res Commun; 2019 Jun; 513(3):553-559. PubMed ID: 30981498 [TBL] [Abstract][Full Text] [Related]
5. The PNPLA3 I148M variant promotes lipid-induced hepatocyte secretion of CXC chemokines establishing a tumorigenic milieu. Nischalke HD; Lutz P; Bartok E; Krämer B; Langhans B; Frizler R; Berg T; Hampe J; Buch S; Datz C; Stickel F; Hartmann G; Strassburg CP; Nattermann J; Spengler U J Mol Med (Berl); 2019 Nov; 97(11):1589-1600. PubMed ID: 31637480 [TBL] [Abstract][Full Text] [Related]
6. PNPLA3-I148M: a problem of plenty in non-alcoholic fatty liver disease. Basu Ray S Adipocyte; 2019 Dec; 8(1):201-208. PubMed ID: 31062641 [TBL] [Abstract][Full Text] [Related]
11. Distinct regulation of adiponutrin/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes. Dubuquoy C; Robichon C; Lasnier F; Langlois C; Dugail I; Foufelle F; Girard J; Burnol AF; Postic C; Moldes M J Hepatol; 2011 Jul; 55(1):145-53. PubMed ID: 21145868 [TBL] [Abstract][Full Text] [Related]
12. ATGL Promotes Autophagy/Lipophagy via SIRT1 to Control Hepatic Lipid Droplet Catabolism. Sathyanarayan A; Mashek MT; Mashek DG Cell Rep; 2017 Apr; 19(1):1-9. PubMed ID: 28380348 [TBL] [Abstract][Full Text] [Related]
13. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease. Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907 [TBL] [Abstract][Full Text] [Related]
14. Impairment of lipophagy by PNPLA1 mutations causes lipid droplet accumulation in primary fibroblasts of Autosomal Recessive Congenital Ichthyosis patients. Onal G; Kutlu O; Ozer E; Gozuacik D; Karaduman A; Dokmeci Emre S J Dermatol Sci; 2019 Jan; 93(1):50-57. PubMed ID: 30655104 [TBL] [Abstract][Full Text] [Related]
15. PNPLA3 downregulation exacerbates the fibrotic response in human hepatic stellate cells. Rady B; Nishio T; Dhar D; Liu X; Erion M; Kisseleva T; Brenner DA; Pocai A PLoS One; 2021; 16(12):e0260721. PubMed ID: 34879108 [TBL] [Abstract][Full Text] [Related]
16. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease. Zhang H; Lu J; Liu H; Guan L; Xu S; Wang Z; Qiu Y; Liu H; Peng L; Men X Pharmacol Res; 2021 Dec; 174():105964. PubMed ID: 34732369 [TBL] [Abstract][Full Text] [Related]
17. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis. Smagris E; BasuRay S; Li J; Huang Y; Lai KM; Gromada J; Cohen JC; Hobbs HH Hepatology; 2015 Jan; 61(1):108-18. PubMed ID: 24917523 [TBL] [Abstract][Full Text] [Related]
18. Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy. Guan L; Guo L; Zhang H; Liu H; Zhou W; Zhai Y; Yan X; Men X; Peng L Mol Nutr Food Res; 2024 Feb; 68(3):e2200812. PubMed ID: 38054638 [TBL] [Abstract][Full Text] [Related]
19. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro. Pirazzi C; Adiels M; Burza MA; Mancina RM; Levin M; Ståhlman M; Taskinen MR; Orho-Melander M; Perman J; Pujia A; Andersson L; Maglio C; Montalcini T; Wiklund O; Borén J; Romeo S J Hepatol; 2012 Dec; 57(6):1276-82. PubMed ID: 22878467 [TBL] [Abstract][Full Text] [Related]
20. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery. Krawczyk M; Jiménez-Agüero R; Alustiza JM; Emparanza JI; Perugorria MJ; Bujanda L; Lammert F; Banales JM Surg Obes Relat Dis; 2016 Dec; 12(10):1838-1846. PubMed ID: 27576208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]